phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

Indiana just joined West Virginia and Arkansas in delivering an important win for Hoosiers who are struggling to afford their medicines. This week, Governor Holcomb signed into law Senate Bill 8 recently passed by the Indiana legislature. This new law will ensure that Indiana patients aren’t paying more for their medicines than their health insurance company or the middlemen known as pharmacy benefit managers (PBMs). 

This concept, known as “share the savings,” puts money back in patients’ pockets by requiring insurers and the PBMs they work with to share the rebates, discounts, and other price concessions they receive from manufacturers directly with patients at the pharmacy counter.

Negotiations between pharmaceutical companies, health insurers, PBMs and others result in significant rebates and discounts that totaled $236 billion in 2021. However, those savings aren’t always shared with patients, which means there are patients who end up paying more for their medicine than their insurer and PBM. This legislation requires 85% of the rebates health insurance companies receive from manufacturers be applied to lower drug costs for patients at the pharmacy counter in Indiana’s individual market and requires insurers to pass through 100% of rebates to plan sponsors (employers) in the fully insured group market, which employers can decide how to share with enrollees. This means lower out-of-pocket costs for Hoosiers, as well as an increased likelihood of better health outcomes as more people will take their medicine as prescribed.  

A recent 50-state poll conducted by Morning Consult on behalf of PhRMA found that strong majorities in every state, including Indiana, agree lowering out-of-pocket costs for health care should be a top policy priority. Specifically: 

•    80% of adults in Indiana support a law that would prevent patients from paying more for their prescription medicine than their insurance company or pharmacy benefit manager (PBM).

•    82% of respondents in Indiana agreed elected officials should ensure health insurance companies and middlemen are held accountable for their role in keeping patients from the medicines they need. 

Indiana patients should have access to affordable medicines, and this legislation is a significant step toward achieving that goal. 

To learn more, visit PhRMA.org/States

Reid Porter

Reid Porter is senior director of public affairs at PhRMA, where he focuses on key policy priorities, member engagement and state media relations. He brings over two decades of experience leading communications and managing complex issues across the biopharmaceutical, technology and energy sectors. Porter holds a B.A. from Middlebury College, where he double‑majored in English and Spanish, and a graduate certificate in Publishing from Columbia University. Outside of work, he enjoys writing, traveling, cheering for the Green Bay Packers, playing and watching soccer, playing the violin, rereading Hemingway novels and spending time with family.

Insurers are blaming medicines for premium hikes in Massachusetts. The state's own data suggests otherwise.

June 24, 2026

340B is growing, but it is unclear if Illinois patients benefit

May 27, 2026

State price-setting boards create more questions than answers

May 20, 2026

States should avoid repeating the IRA’s price‑setting mistakes 

April 21, 2026

A win for Indiana patients: “Sharing the savings” legislation now law

State Policy

share the savings

A win for Indiana patients: “Sharing the savings” legislation now law

May 8, 2023

A win for Indiana patients: “Sharing the savings” legislation now law

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list